1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Phase 1 1.2.3 Phase 2 1.2.4 Preclinical 1.3 Market by Application 1.3.1 Global Ischemia Reperfusion Injury Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Heart Injury 1.3.3 Kidney Injury 1.3.4 Intestine Injury 1.3.5 Other Injury 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ischemia Reperfusion Injury Market Perspective (2016-2027) 2.2 Ischemia Reperfusion Injury Growth Trends by Regions 2.2.1 Ischemia Reperfusion Injury Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ischemia Reperfusion Injury Historic Market Share by Regions (2016-2021) 2.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Regions (2022-2027) 2.3 Ischemia Reperfusion Injury Industry Dynamic 2.3.1 Ischemia Reperfusion Injury Market Trends 2.3.2 Ischemia Reperfusion Injury Market Drivers 2.3.3 Ischemia Reperfusion Injury Market Challenges 2.3.4 Ischemia Reperfusion Injury Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ischemia Reperfusion Injury Players by Revenue 3.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2016-2021) 3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2016-2021) 3.2 Global Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ischemia Reperfusion Injury Revenue 3.4 Global Ischemia Reperfusion Injury Market Concentration Ratio 3.4.1 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Revenue in 2020 3.5 Ischemia Reperfusion Injury Key Players Head office and Area Served 3.6 Key Players Ischemia Reperfusion Injury Product Solution and Service 3.7 Date of Enter into Ischemia Reperfusion Injury Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ischemia Reperfusion Injury Breakdown Data by Type 4.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2016-2021) 4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2022-2027) 5 Ischemia Reperfusion Injury Breakdown Data by Application 5.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2016-2021) 5.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ischemia Reperfusion Injury Market Size (2016-2027) 6.2 North America Ischemia Reperfusion Injury Market Size by Type 6.2.1 North America Ischemia Reperfusion Injury Market Size by Type (2016-2021) 6.2.2 North America Ischemia Reperfusion Injury Market Size by Type (2022-2027) 6.2.3 North America Ischemia Reperfusion Injury Market Size by Type (2016-2027) 6.3 North America Ischemia Reperfusion Injury Market Size by Application 6.3.1 North America Ischemia Reperfusion Injury Market Size by Application (2016-2021) 6.3.2 North America Ischemia Reperfusion Injury Market Size by Application (2022-2027) 6.3.3 North America Ischemia Reperfusion Injury Market Size by Application (2016-2027) 6.4 North America Ischemia Reperfusion Injury Market Size by Country 6.4.1 North America Ischemia Reperfusion Injury Market Size by Country (2016-2021) 6.4.2 North America Ischemia Reperfusion Injury Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Ischemia Reperfusion Injury Market Size (2016-2027) 7.2 Europe Ischemia Reperfusion Injury Market Size by Type 7.2.1 Europe Ischemia Reperfusion Injury Market Size by Type (2016-2021) 7.2.2 Europe Ischemia Reperfusion Injury Market Size by Type (2022-2027) 7.2.3 Europe Ischemia Reperfusion Injury Market Size by Type (2016-2027) 7.3 Europe Ischemia Reperfusion Injury Market Size by Application 7.3.1 Europe Ischemia Reperfusion Injury Market Size by Application (2016-2021) 7.3.2 Europe Ischemia Reperfusion Injury Market Size by Application (2022-2027) 7.3.3 Europe Ischemia Reperfusion Injury Market Size by Application (2016-2027) 7.4 Europe Ischemia Reperfusion Injury Market Size by Country 7.4.1 Europe Ischemia Reperfusion Injury Market Size by Country (2016-2021) 7.4.2 Europe Ischemia Reperfusion Injury Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2016-2027) 8.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type 8.2.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2027) 8.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application 8.3.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2027) 8.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region 8.4.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ischemia Reperfusion Injury Market Size (2016-2027) 9.2 Latin America Ischemia Reperfusion Injury Market Size by Type 9.2.1 Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2021) 9.2.2 Latin America Ischemia Reperfusion Injury Market Size by Type (2022-2027) 9.2.3 Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2027) 9.3 Latin America Ischemia Reperfusion Injury Market Size by Application 9.3.1 Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2021) 9.3.2 Latin America Ischemia Reperfusion Injury Market Size by Application (2022-2027) 9.3.3 Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2027) 9.4 Latin America Ischemia Reperfusion Injury Market Size by Country 9.4.1 Latin America Ischemia Reperfusion Injury Market Size by Country (2016-2021) 9.4.2 Latin America Ischemia Reperfusion Injury Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2016-2027) 10.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type 10.2.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2027) 10.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application 10.3.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2027) 10.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country 10.4.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Angion Biomedica 11.1.1 Angion Biomedica Company Details 11.1.2 Angion Biomedica Business Overview 11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction 11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.1.5 Angion Biomedica Recent Development 11.2 Catalyst Biosciences 11.2.1 Catalyst Biosciences Company Details 11.2.2 Catalyst Biosciences Business Overview 11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction 11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.2.5 Catalyst Biosciences Recent Development 11.3 Ischemix Inc 11.3.1 Ischemix Inc Company Details 11.3.2 Ischemix Inc Business Overview 11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction 11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.3.5 Ischemix Inc Recent Development 11.4 Opsona Therapeutics 11.4.1 Opsona Therapeutics Company Details 11.4.2 Opsona Therapeutics Business Overview 11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction 11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.4.5 Opsona Therapeutics Recent Development 11.5 Pharming 11.5.1 Pharming Company Details 11.5.2 Pharming Business Overview 11.5.3 Pharming Ischemia Reperfusion Injury Introduction 11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.5.5 Pharming Recent Development 11.6 TheraSource 11.6.1 TheraSource Company Details 11.6.2 TheraSource Business Overview 11.6.3 TheraSource Ischemia Reperfusion Injury Introduction 11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.6.5 TheraSource Recent Development 11.7 Bolder Biotechnology 11.7.1 Bolder Biotechnology Company Details 11.7.2 Bolder Biotechnology Business Overview 11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction 11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.7.5 Bolder Biotechnology Recent Development 11.8 Corline Biomedical 11.8.1 Corline Biomedical Company Details 11.8.2 Corline Biomedical Business Overview 11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction 11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.8.5 Corline Biomedical Recent Development 11.9 Mifcortx 11.9.1 Mifcortx Company Details 11.9.2 Mifcortx Business Overview 11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction 11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.9.5 Mifcortx Recent Development 11.10 Balmes Transplantation 11.10.1 Balmes Transplantation Company Details 11.10.2 Balmes Transplantation Business Overview 11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction 11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.10.5 Balmes Transplantation Recent Development 11.11 NovelMed Therapeutics 11.11.1 NovelMed Therapeutics Company Details 11.11.2 NovelMed Therapeutics Business Overview 11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction 11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.11.5 NovelMed Therapeutics Recent Development 11.12 Hope Pharmaceuticals 11.12.1 Hope Pharmaceuticals Company Details 11.12.2 Hope Pharmaceuticals Business Overview 11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction 11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.12.5 Hope Pharmaceuticals Recent Development 11.13 Omeros Corp 11.13.1 Omeros Corp Company Details 11.13.2 Omeros Corp Business Overview 11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction 11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.13.5 Omeros Corp Recent Development 11.14 Prothix 11.14.1 Prothix Company Details 11.14.2 Prothix Business Overview 11.14.3 Prothix Ischemia Reperfusion Injury Introduction 11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.14.5 Prothix Recent Development 11.15 SBI Pharmaceuticals 11.15.1 SBI Pharmaceuticals Company Details 11.15.2 SBI Pharmaceuticals Business Overview 11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction 11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) 11.15.5 SBI Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Phase 1 Table 3. Key Players of Phase 2 Table 4. Key Players of Preclinical Table 5. Global Ischemia Reperfusion Injury Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Ischemia Reperfusion Injury Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Ischemia Reperfusion Injury Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Ischemia Reperfusion Injury Market Share by Regions (2016-2021) Table 9. Global Ischemia Reperfusion Injury Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Ischemia Reperfusion Injury Market Share by Regions (2022-2027) Table 11. Ischemia Reperfusion Injury Market Trends Table 12. Ischemia Reperfusion Injury Market Drivers Table 13. Ischemia Reperfusion Injury Market Challenges Table 14. Ischemia Reperfusion Injury Market Restraints Table 15. Global Ischemia Reperfusion Injury Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Ischemia Reperfusion Injury Market Share by Players (2016-2021) Table 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemia Reperfusion Injury as of 2020) Table 18. Ranking of Global Top Ischemia Reperfusion Injury Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Ischemia Reperfusion Injury Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Ischemia Reperfusion Injury Product Solution and Service Table 22. Date of Enter into Ischemia Reperfusion Injury Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 25. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2016-2021) Table 26. Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Ischemia Reperfusion Injury Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2016-2021) Table 30. Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 33. North America Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million) Table 35. North America Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million) Table 62. Angion Biomedica Company Details Table 63. Angion Biomedica Business Overview Table 64. Angion Biomedica Ischemia Reperfusion Injury Product Table 65. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 66. Angion Biomedica Recent Development Table 67. Catalyst Biosciences Company Details Table 68. Catalyst Biosciences Business Overview Table 69. Catalyst Biosciences Ischemia Reperfusion Injury Product Table 70. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 71. Catalyst Biosciences Recent Development Table 72. Ischemix Inc Company Details Table 73. Ischemix Inc Business Overview Table 74. Ischemix Inc Ischemia Reperfusion Injury Product Table 75. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 76. Ischemix Inc Recent Development Table 77. Opsona Therapeutics Company Details Table 78. Opsona Therapeutics Business Overview Table 79. Opsona Therapeutics Ischemia Reperfusion Injury Product Table 80. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 81. Opsona Therapeutics Recent Development Table 82. Pharming Company Details Table 83. Pharming Business Overview Table 84. Pharming Ischemia Reperfusion Injury Product Table 85. Pharming Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 86. Pharming Recent Development Table 87. TheraSource Company Details Table 88. TheraSource Business Overview Table 89. TheraSource Ischemia Reperfusion Injury Product Table 90. TheraSource Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 91. TheraSource Recent Development Table 92. Bolder Biotechnology Company Details Table 93. Bolder Biotechnology Business Overview Table 94. Bolder Biotechnology Ischemia Reperfusion Injury Product Table 95. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 96. Bolder Biotechnology Recent Development Table 97. Corline Biomedical Company Details Table 98. Corline Biomedical Business Overview Table 99. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 100. Corline Biomedical Recent Development Table 101. Mifcortx Company Details Table 102. Mifcortx Business Overview Table 103. Mifcortx Ischemia Reperfusion Injury Product Table 104. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 105. Mifcortx Recent Development Table 106. Balmes Transplantation Company Details Table 107. Balmes Transplantation Business Overview Table 108. Balmes Transplantation Ischemia Reperfusion Injury Product Table 109. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 110. Balmes Transplantation Recent Development Table 111. NovelMed Therapeutics Company Details Table 112. NovelMed Therapeutics Business Overview Table 113. NovelMed Therapeutics Ischemia Reperfusion Injury Product Table 114. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 115. NovelMed Therapeutics Recent Development Table 116. Hope Pharmaceuticals Company Details Table 117. Hope Pharmaceuticals Business Overview Table 118. Hope Pharmaceuticals Ischemia Reperfusion Injury Product Table 119. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 120. Hope Pharmaceuticals Recent Development Table 121. Omeros Corp Company Details Table 122. Omeros Corp Business Overview Table 123. Omeros Corp Ischemia Reperfusion Injury Product Table 124. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 125. Omeros Corp Recent Development Table 126. Prothix Company Details Table 127. Prothix Business Overview Table 128. Prothix Ischemia Reperfusion Injury Product Table 129. Prothix Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 130. Prothix Recent Development Table 131. SBI Pharmaceuticals Company Details Table 132. SBI Pharmaceuticals Business Overview Table 133. SBI Pharmaceuticals Ischemia Reperfusion Injury Product Table 134. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million) Table 135. SBI Pharmaceuticals Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Ischemia Reperfusion Injury Market Share by Type: 2020 VS 2027 Figure 2. Phase 1 Features Figure 3. Phase 2 Features Figure 4. Preclinical Features Figure 5. Global Ischemia Reperfusion Injury Market Share by Application: 2020 VS 2027 Figure 6. Heart Injury Case Studies Figure 7. Kidney Injury Case Studies Figure 8. Intestine Injury Case Studies Figure 9. Other Injury Case Studies Figure 10. Ischemia Reperfusion Injury Report Years Considered Figure 11. Global Ischemia Reperfusion Injury Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Ischemia Reperfusion Injury Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Ischemia Reperfusion Injury Market Share by Regions: 2020 VS 2027 Figure 14. Global Ischemia Reperfusion Injury Market Share by Regions (2022-2027) Figure 15. Global Ischemia Reperfusion Injury Market Share by Players in 2020 Figure 16. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemia Reperfusion Injury as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Ischemia Reperfusion Injury Revenue in 2020 Figure 18. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2016-2021) Figure 19. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2022-2027) Figure 20. North America Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Ischemia Reperfusion Injury Market Share by Type (2016-2027) Figure 22. North America Ischemia Reperfusion Injury Market Share by Application (2016-2027) Figure 23. North America Ischemia Reperfusion Injury Market Share by Country (2016-2027) Figure 24. United States Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Ischemia Reperfusion Injury Market Share by Type (2016-2027) Figure 28. Europe Ischemia Reperfusion Injury Market Share by Application (2016-2027) Figure 29. Europe Ischemia Reperfusion Injury Market Share by Country (2016-2027) Figure 30. Germany Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Ischemia Reperfusion Injury Market Share by Type (2016-2027) Figure 38. Asia-Pacific Ischemia Reperfusion Injury Market Share by Application (2016-2027) Figure 39. Asia-Pacific Ischemia Reperfusion Injury Market Share by Region (2016-2027) Figure 40. China Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Ischemia Reperfusion Injury Market Share by Type (2016-2027) Figure 48. Latin America Ischemia Reperfusion Injury Market Share by Application (2016-2027) Figure 49. Latin America Ischemia Reperfusion Injury Market Share by Country (2016-2027) Figure 50. Mexico Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Ischemia Reperfusion Injury Market Share by Type (2016-2027) Figure 54. Middle East & Africa Ischemia Reperfusion Injury Market Share by Application (2016-2027) Figure 55. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2016-2027) Figure 56. Turkey Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Angion Biomedica Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 60. Catalyst Biosciences Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 61. Ischemix Inc Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 62. Opsona Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 63. Pharming Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 64. TheraSource Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 65. Bolder Biotechnology Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 66. Corline Biomedical Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 67. Mifcortx Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 68. Balmes Transplantation Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 69. NovelMed Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 70. Hope Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 71. Omeros Corp Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 72. Prothix Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 73. SBI Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Angion Biomedica Catalyst Biosciences Ischemix Inc Opsona Therapeutics Pharming TheraSource Bolder Biotechnology Corline Biomedical Mifcortx Balmes Transplantation NovelMed Therapeutics Hope Pharmaceuticals Omeros Corp Prothix SBI Pharmaceuticals